SFRP4 and gastric cancer: The group with high SFRP4 expression in gastric cancer tissues had a poorer 5-year OS rate (P=0.021), where the 5-year OS rates in the low and high SFRP4 expression groups were 60.02% and 39.81%, respectively (Figure 6(a)).